BioSpace News Archive

BioCapital

Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind

60 Degrees Pharmaceuticals, Inc. announced it has entered into an agreement with Tufts Medical Center in Boston to conduct the world’s first clinical trial evaluating the efficacy and safety of tafenoquine in treating human babesiosis patients.

May 30, 2024
·
11 min read
Biotech Bay

Terns Pharmaceuticals to Participate in Upcoming June 2024 Investor Conferences

Terns Pharmaceuticals, Inc. announced that members of senior management will be participating in the following upcoming investor conferences in June.

May 30, 2024
·
1 min read
Genetown

Prime Medicine to Present at Upcoming Investor Conferences

Prime Medicine, Inc. today announced that Keith Gottesdiener, M.D., President and Chief Executive Officer will present at two upcoming investor conferences.

May 30, 2024
·
2 min read
Bio NC

Humacyte to Present at the Jefferies Global Healthcare Conference

Humacyte, Inc. today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, will present at the Jefferies Global Healthcare Conference, in New York, NY on Thursday, June 6, 2024.

May 30, 2024
·
2 min read
Genetown

Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

Corbus Pharmaceuticals Holdings, Inc. today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will provide a corporate update and participate in one-on-one investor meetings at the 45th Annual Goldman Sachs Global Healthcare Conference to be held June 10-13, 2024 in Miami Beach, FL.

May 30, 2024
·
3 min read
Genetown

ORYZON to Provide Corporate Progress Updates at Several Events in June

Oryzon Genomics, S.A announced today that its management will give an update on corporate progress at several international events in June.

May 30, 2024
·
8 min read
Biotech Bay

Rezolute to Participate in the Jefferies Global Healthcare Conference

Rezolute, Inc. for serious metabolic and rare diseases, today announced that Nevan Charles Elam, Chief Executive Officer and Founder of Rezolute, will participate in a fireside chat during the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 1:00 p.m. ET in New York City.

May 30, 2024
·
1 min read
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis

Olink Holding AB reported the publication of a landmark study using the Olink Explore platform to identify proteins in the blood that may provide a 7-year warning for various cancers.

May 30, 2024
·
5 min read
Drug Development

BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast Cancer

BriaCell Therapeutics Corp. announces initiation of a first-in-human, Phase 1/2 study evaluating safety and efficacy of Bria-OTS™.

May 30, 2024
·
4 min read
Biotech Beach

Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping Workflow

Bionano Genomics, Inc. announced the Company’s robust participation at two upcoming cytogenetics conferences.

May 30, 2024
·
14 min read